1. Academic Validation
  2. Interleukin-38 promotes skin tumorigenesis in an IL-1Rrp2-dependent manner

Interleukin-38 promotes skin tumorigenesis in an IL-1Rrp2-dependent manner

  • EMBO Rep. 2022 Jun 7;23(6):e53791. doi: 10.15252/embr.202153791.
Hong Zhou  # 1 Qixiang Zhao  # 1 Chengcheng Yue  # 1 Jiadong Yu  # 1 Huaping Zheng 1 Jing Hu 1 Zhonglan Hu 1 Haozhou Zhang 1 Xiu Teng 1 Xiao Liu 1 Xiaoqiong Wei 1 Yuxi Zhou 2 Fanlian Zeng 1 Yan Hao 1 Yawen Hu 1 Xiaoyan Wang 1 Chen Zhang 1 Linna Gu 1 Wenling Wu 1 Yifan Zhou 1 Kaijun Cui 3 Nongyu Huang 1 Wei Li 2 Zhen Wang 1 4 Jiong Li 1
Affiliations

Affiliations

  • 1 State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu, China.
  • 2 Department of Dermatovenereology, West China Hospital, Sichuan University, Chengdu, China.
  • 3 Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China.
  • 4 Department of Liver Surgery & Liver Transplantation, West China Hospital, Sichuan University and Collaborative Innovation Center of Biotherapy, Chengdu, China.
  • # Contributed equally.
Abstract

Interleukin-38 (IL-38) is strongly associated with chronic inflammatory diseases; however, its role in tumorigenesis is poorly understood. We demonstrated that expression of IL-38, which exhibits high expression in the skin, is downregulated in human cutaneous squamous cell carcinoma and 7,12-dimethylbenzanthracene/12-O-tetradecanoyl phorbol-13-acetate-induced mouse skin tumorigenesis. IL-38 keratinocyte-specific knockout mice displayed suppressed skin tumor formation and malignant progression. Keratinocyte-specific deletion of IL-38 was associated with reduced expression of inflammatory cytokines, leading to reduced myeloid cell infiltration into the local tumor microenvironment. IL-38 is dispensable for epidermal mutagenesis, but IL-38 keratinocyte-specific deletion reduces proliferative gene expression along with epidermal cell proliferation and hyperplasia. Mechanistically, we first demonstrated that IL-38 activates the c-Jun N-terminal kinase (JNK)/activator protein 1 signal transduction pathway to promote the expression of cancer-related inflammatory cytokines and proliferation and migration of tumor cells in an IL-1 receptor-related protein 2 (IL-1Rrp2)-dependent manner. Our findings highlight the role of IL-38 in the regulation of epidermal cell hyperplasia and pro-tumorigenic microenvironment through IL-1Rrp2/JNK and suggest IL-38/IL-1Rrp2 as a preventive and potential therapeutic target in skin Cancer.

Keywords

IL-1Rrp2; IL-38; skin carcinogenesis.

Figures
Products